Literature DB >> 9618651

Molecular prognostic markers and colorectal cancer: the search goes on.

D C Chung.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9618651     DOI： 10.1016/s0016-5085(98)70441-x

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  9 in total

1.  Immunoprofiles of 11 biomarkers using tissue microarrays identify prognostic subgroups in colorectal cancer.

Authors:  Thomas Knösel; Anna Emde; Karsten Schlüns; Yuan Chen; Karsten Jürchott; Matthias Krause; Manfred Dietel; Iver Petersen
Journal:  Neoplasia       Date:  2005-08       Impact factor: 5.715

2.  Molecular predictors of survival after adjuvant chemotherapy for colon cancer.

Authors:  T Watanabe; T T Wu; P J Catalano; T Ueki; R Satriano; D G Haller; A B Benson; S R Hamilton
Journal:  N Engl J Med       Date:  2001-04-19       Impact factor: 91.245

3.  Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma.

Authors:  A I Sarela; R C Macadam; S M Farmery; A F Markham; P J Guillou
Journal:  Gut       Date:  2000-05       Impact factor: 23.059

4.  Caspase-3 activity, response to chemotherapy and clinical outcome in patients with colon cancer.

Authors:  Javier de Oca; Daniel Azuara; Raquel Sanchez-Santos; Matilde Navarro; Gabriel Capella; Victor Moreno; Anna Sola; Georgina Hotter; Sebastiano Biondo; Alfonso Osorio; Joan Martí-Ragué; Antoni Rafecas
Journal:  Int J Colorectal Dis       Date:  2007-09-04       Impact factor: 2.571

5.  Expression of p21(WAF1) is related to acetylation of histone H3 in total chromatin in human colorectal cancer.

Authors:  Ying-Xuan Chen; Jing-Yuan Fang; Rong Lu; De-Kai Qiu
Journal:  World J Gastroenterol       Date:  2007-04-21       Impact factor: 5.742

6.  Extent of mesorectal tumor invasion as a prognostic factor after curative surgery for T3 rectal cancer patients.

Authors:  Masayoshi Miyoshi; Hideki Ueno; Yojiro Hashiguchi; Hidetaka Mochizuki; Ian C Talbot
Journal:  Ann Surg       Date:  2006-04       Impact factor: 12.969

7.  Loss of MUC2 expression predicts disease recurrence and poor outcome in colorectal carcinoma.

Authors:  Adam Elzagheid; Fatma Emaetig; Abdelbaset Buhmeida; Matti Laato; Omran El-Faitori; Kari Syrjänen; Yrjö Collan; Seppo Pyrhönen
Journal:  Tumour Biol       Date:  2012-11-21

8.  Overexpression of c-erbB-2 protein correlates with chromosomal gain at the c-erbB-2 locus and patient survival in advanced colorectal carcinomas.

Authors:  Thomas Knösel; Youngwei Yu; Ulrike Stein; Holger Schwabe; Karsten Schlüns; Peter Michael Schlag; Manfred Dietel; Iver Petersen
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

9.  Chromosome 18q deletion and Smad4 protein inactivation correlate with liver metastasis: A study matched for T- and N- classification.

Authors:  T Tanaka; T Watanabe; Y Kazama; J Tanaka; T Kanazawa; S Kazama; H Nagawa
Journal:  Br J Cancer       Date:  2006-11-07       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.